Tandem Diabetes Care Inc reports results for the quarter ended December 31 - Earnings Summary

Tandem Diabetes Care

26/02/2025 23:16

Tandem Diabetes Care Inc TNDM.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -27 cents.  The mean expectation of twenty one analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -37 cents to -4 cents per share.

Revenue rose 43.6% to $282.65 million from a year ago; analysts expected $251.98 million.

Tandem Diabetes Care Inc's reported EPS for the quarter was 1 cent​.

The company reported quarterly net income of $755 thousand.

Tandem Diabetes Care Inc shares had fallen by 7.4% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 0.9% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell."

The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Tandem Diabetes Care Inc is $56.50

This summary was machine generated from LSEG data February 26 at 11:16 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.23
0.01
Beat
Sep. 30 2024
-0.41
-0.35
Beat
Jun. 30 2024
-0.54
-0.48
Beat
Mar. 31 2024
-0.76
-0.63
Beat